Lejla Vajzovic, MD, FASRS
Healio spoke with Lejla Vajzovic, MD, FASRS, associate professor of ophthalmology, adult and pediatric vitreoretinal surgery and disease, Duke University Eye Center, about:
- the excitement of having treatment options for patients with inherited retinal diseases as new treatments emerge;
- developments highlighted at Hawaiian Eye and Retina 2023;
- how the only gene therapy currently FDA-approved to treat Leber congenital amaurosis has “sparked interest” into “diving deeper into genetic analyses” for retinal diseases;
- the 40+ clinical trials currently ongoing in the IRD space;
- the promise of gene therapy in “more common retinal diseases” like wet AMD and diabetic retinopathy;
- challenges of understanding subtle signs of vision changes early in patients;
- sharing with patients that genetic testing can help diagnose and treat conditions earlier; and
- comparing the role of genetic predispositions in IRD risk between the sexes.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.